Literature DB >> 33802075

A New Family of Benzo[h]Chromene Based Azo Dye: Synthesis, In-Silico and DFT Studies with In Vitro Antimicrobial and Antiproliferative Assessment.

Alaa S Abd-El-Aziz1, Azhaar Alsaggaf1,2, Eman Assirey1,2, Arshi Naqvi2, Rawda M Okasha2, Tarek H Afifi2, Mohamed Hagar3,4.   

Abstract

The high biological activity of the chromene compounds coupled with the intriguing optical features of n class="Chemical">azo chromophores prompted our desire to construct novel derivatives of chromene incorporating azo moieties 4a-l, which have been prepared via a three-component reaction of 1-naphthalenol-4-[(4-ethoxyphenyl) azo], 1, with the benzaldehyde derivatives and malononitrile. The structural identities of the azo-chromene 4a-l were confirmed on the basis of their spectral data and elemental analysis, and a UV-visible study was performed in a Dimethylformamide (DMF) solution for these molecules. Additionally, the antimicrobial activity was investigated against four human pathogens (Gram-positive and Gram-negative bacteria) and four fungi, employing an agar well diffusion method, with their minimum inhibitory concentrations being reported. Molecules 4a, 4g, and 4h were discovered to be more efficacious against Syncephalastrum racemosum (RCMB 05922) in comparison to the reference drugs, while compounds 4b and 4h demonstrated the highest inhibitory activity against Escherichia coli (E. coli) in evaluation against the reference drugs. Moreover, their cytotoxicity was assessed against three different human cell lines, including human colon carcinoma (HCT-116), human hepatocellular carcinoma (HepG-2), and human breast adenocarcinoma (MCF-7) with a selection of molecules illustrating potency against the HCT-116 and MCF-7 cell lines. Furthermore, the molecular modeling results depicted the binding interactions of the synthesized compounds 3b and 3h in the active site of the E. coli DNA gyrase B enzyme with a clear SAR (structure-activity relationship) analysis. Lastly, the density functional theory's (DFTs) theoretical calculations were performed to quantify the energy levels of the Frontier Molecular Orbitals (FMOs) and their energy gaps, dipole moments, and molecular electrostatic potentials. These data were utilized in the chemical descriptor estimations to confirm the biological activity.

Entities:  

Keywords:  DFT calculations; SAR; azo chromene dyes; biological assessment; molecular docking

Mesh:

Substances:

Year:  2021        PMID: 33802075      PMCID: PMC7998172          DOI: 10.3390/ijms22062807

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  38 in total

1.  Quantitative structure-property relationships in pharmaceutical research - Part 1.

Authors: 
Journal:  Pharm Sci Technolo Today       Date:  2000-01

Review 2.  Azo dyes and human health: A review.

Authors:  King-Thom Chung
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2016-10       Impact factor: 3.781

Review 3.  Heterocyclic azo dyestuffs in analytical chemistry. A review.

Authors:  R G Anderson; G Nickless
Journal:  Analyst       Date:  1967-04       Impact factor: 4.616

4.  A synthetic study on antiviral and antioxidative chromene derivative.

Authors:  Jun Mori; Makoto Iwashima; Makoto Takeuchi; Haruo Saito
Journal:  Chem Pharm Bull (Tokyo)       Date:  2006-03       Impact factor: 1.645

5.  A new chiral boron-dipyrromethene (BODIPY)-based fluorescent probe: molecular docking, DFT, antibacterial and antioxidant approaches.

Authors:  Rua B Alnoman; Shazia Parveen; Mohamad Hagar; Hoda A Ahmed; Julian G Knight
Journal:  J Biomol Struct Dyn       Date:  2019-12-19

6.  Synthesis of novel 3-(4-acetyl-5H/methyl-5-substituted phenyl-4,5-dihydro-1,3,4-oxadiazol-2-yl)-2H-chromen-2-ones as potential anticonvulsant agents.

Authors:  Mashooq A Bhat; Nadeem Siddiqui; Suroor A Khan
Journal:  Acta Pol Pharm       Date:  2008 Mar-Apr       Impact factor: 0.330

7.  Antivascular and antitumor evaluation of 2-amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-4H-chromenes, a novel series of anticancer agents.

Authors:  Henriette Gourdeau; Lorraine Leblond; Bettina Hamelin; Clemence Desputeau; Kelly Dong; Irenej Kianicka; Dominique Custeau; Chantal Boudreau; Lilianne Geerts; Sui-Xiong Cai; John Drewe; Denis Labrecque; Shailaja Kasibhatla; Ben Tseng
Journal:  Mol Cancer Ther       Date:  2004-11       Impact factor: 6.261

8.  Design of New Benzo[h]chromene Derivatives: Antitumor Activities and Structure-Activity Relationships of the 2,3-Positions and Fused Rings at the 2,3-Positions.

Authors:  Rawda M Okasha; Fawzia F Alblewi; Tarek H Afifi; Arshi Naqvi; Ahmed M Fouda; Al-Anood M Al-Dies; Ahmed M El-Agrody
Journal:  Molecules       Date:  2017-03-18       Impact factor: 4.411

9.  Introducing novel potent anticancer agents of 1H-benzo[f]chromene scaffolds, targeting c-Src kinase enzyme with MDA-MB-231 cell line anti-invasion effect.

Authors:  Hany E A Ahmed; Mohammed A A El-Nassag; Ahmed H Hassan; Rawda M Okasha; Saleh Ihmaid; Ahmed M Fouda; Tarek H Afifi; Ateyatallah Aljuhani; Ahmed M El-Agrody
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

Review 10.  Review on natural coumarin lead compounds for their pharmacological activity.

Authors:  K N Venugopala; V Rashmi; B Odhav
Journal:  Biomed Res Int       Date:  2013-03-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.